Skip to content

Effect of high altitude on the development of type 2 diabetes

Study on intestinal microflora and metabonomics of high altitude and hypoxia regulating the glucose homeostasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016854
Enrollment
Unknown
Registered
2018-06-28
Start date
2018-08-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

lower altitude observation group:Nil
lower altitude validation group:Nil
higher altitude group:Nil

Sponsors

Nyingchi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Chinese residents living at plateau or plain with age from 18~65 years.Gender is not limited.A body mass index 18.5~30kg/m2. All subjects sign an informed consent before enrollment. 1. Plateau: The altitude height is 2900m. Plain: The altitude height is less than 50m. 2. Residents: More than 5 years of residency,a cumulative time of leaving per year is limited to 3 months and each time period out-of-home is limited to 1 month.Subjects haven't been away from places of residence during 6 months before enrollment.

Exclusion criteria

Exclusion criteria: 1. Impaired glucose tolerance or diabetes. 2. A history of gastrointestinal surgery;irritable bowel syndrome, inflammatory bowel disease, etc. 3. Chronic obstructive pulmonary disease;Severe heart, liver or kidney dysfunction;malignant neoplasms. 4. Acute cardiovascular events or stroke during recent a half year. 5. Use of hormones, weight-loss drugs, lipid-lowering drugs or probiotics in the one month before the enrollment. 6. Antibiotic use in the past 3 months.

Design outcomes

Primary

MeasureTime frame
metabolite profiling;gut microbiota;

Secondary

MeasureTime frame
blood glucose level;islet function;lipid profile;Inflammatory indicators;

Countries

China

Contacts

Public ContactDan Liu

Nyingchi People's Hospital

liudanye66@126.com+86 13728067086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026